OKYO Stock Analysis: Buy, Sell, or Hold?
OKYO - OKYO Pharma Limited Ordinary Shares
$1.42
0.02 (1.39%)
▲
5d:
-9.59%
30d:
-5.99%
90d:
-6.61%
WAIT
LOW Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Jul 17, 2026
0d
Get Alerted When OKYO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OKYO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OKYO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OKYO is currently trading at $1.42, which is considered oversold relative to its 30-day fair value range of $1.47 to $1.58.
Technical Outlook: Technically, OKYO is in a downtrend. Immediate support is located at $1.35, while resistance sits at $1.67.
Market Sentiment: OKYO scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.33 (+495.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OKYO is in a downtrend. Immediate support is located at $1.35, while resistance sits at $1.67.
Market Sentiment: OKYO scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.33 (+495.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.47 -
$1.58
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (35/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 495.2% below Wall St target ($8.33)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.47 -
$1.58
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.35
Resistance Level
$1.67
Current Trend
Downtrend
Technical data as of
Sep 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.00
Wall Street Target
$8.33
(+495.2%)
Share & Embed Analysis
Last updated: September 14, 2026 2:18 PM ET
Data refreshes hourly during market hours. Next update: 3:18 PM
Data refreshes hourly during market hours. Next update: 3:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OKYO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 49 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 37 SELL |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 52 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$569 | 38 SELL |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
